Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors (Q63813348)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
clinical trial

    Statements

    short name
    iMATRIXcobi (English)
    0 references
    title
    A Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Cobimetinib In Pediatric and Young Adult Patients With Previously Treated Solid Tumors (English)
    0 references
    sponsor
    Hoffmann-La Roche
    0 references
    country
    Canada
    0 references
    France
    0 references
    Germany
    0 references
    Israel
    0 references
    Italy
    0 references
    Spain
    0 references
    United Kingdom
    0 references
    start time
    20 May 2016
    0 references
    end time
    21 February 2023
    0 references
    number of participants
    50
    0 references
    minimum age
    6 month
    0 references
    maximum age
    30 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q63813348&oldid=2235182539"